Antonio Santos‐Peral

This study shows antibodies against influenza A virus hemagglutinin and neuraminidase reduce virus yield, induce larger particles, and affect subsequent infection.

This study shows that type I interferon, induced by RIG-I-like receptors, restricts YF17D replication in antigen-presenting cells, thereby limiting antigen presentation to T cells.

This study explores the use of viral IFN-I binding protein as a therapeutic to neutralize IFN-I and treat autoinflammatory diseases in mouse models.

The paper identifies IFN-induced activation of dendritic cells and monocytes after yellow fever vaccination as correlated with early protective antibody responses.